Article
Molecular characterization of Helicobacter pylori resistance to rifamycins.
Helicobacter - 1 Feb 2018
Hays Constantin, Burucoa Christophe, Lehours Philippe, Tran Cong Tri, Leleu Anaïs, Raymond Josette
Abstract excerpt
INTRODUCTION: Antibiotic resistance is a major contributing factor in treatment failure of Helicobacter pylori eradication. Rifabutin (RB) is a rescue treatment and rifampicin (RP) is used to screen RB resistance in vitro. The aim of this study was to evaluate the rate of rifamycins resistance and to determine the mutations in the rpoB gene conferring resistance to discuss the current break point. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
